These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1613560)

  • 21. D1/D2 dopamine receptor stimulation by L-dopa. A [14C]-2-deoxyglucose autoradiographic study.
    Trugman JM; James CL; Wooten GF
    Brain; 1991 Jun; 114 ( Pt 3)():1429-40. PubMed ID: 1829645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR; Hu XT; Galloway MP; White FJ
    Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of nigrostriatal dopamine in metabotropic glutamate agonist-induced rotation.
    Kearney JA; Becker JB; Frey KA; Albin RL
    Neuroscience; 1998 Dec; 87(4):881-91. PubMed ID: 9759976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. D1 dopamine receptor stimulation inhibits firing activity of midbrain dopamine neurons in reserpine treated rats: an effect eliminated after hemitransection of diencephalon.
    Sun BC; Chouvet G; Jin GZ
    Synapse; 1996 Sep; 24(1):29-38. PubMed ID: 9046074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of dopaminergic receptor subtypes in straub tail behaviour in mice.
    Zarrindast MR; Bayat A; Shafaghi B
    Gen Pharmacol; 1993 Jan; 24(1):127-30. PubMed ID: 8097737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Threshold of dopamine content and D1 receptor stimulation necessary for the expression of rotational behavior induced by D2 receptor stimulation under normo and supersensitive conditions.
    Dziewczapolski G; Mora MA; Menalled LB; Stéfano FJ; Rubinstein M; Gershanik OS
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jan; 355(1):30-5. PubMed ID: 9007839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of reserpine-induced catalepsy by selective D1 and D2 dopamine agonists.
    Hubbard CA; Trugman JM
    Mov Disord; 1993 Oct; 8(4):473-8. PubMed ID: 7901761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The mode of action of bromocriptine following pretreatment with reserpine and alpha-methyl-p-tyrosine in rats.
    Ushijima I; Mizuki Y; Yamada M
    Psychopharmacology (Berl); 1988; 95(1):29-33. PubMed ID: 2898789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of glutamate antagonists on nigral dopamine release in the reserpine-treated rat.
    Biggs C; Starr M; Fowler L; Whitton P
    Biochem Soc Trans; 1996 Feb; 24(1):173-7. PubMed ID: 8674654
    [No Abstract]   [Full Text] [Related]  

  • 33. 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons.
    Cole DG; Kobierski LA; Konradi C; Hyman SE
    Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9631-5. PubMed ID: 7937819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pressure reversed extracellular striatal dopamine decrease produced by D1 receptor agonist SKF 38393, and D2 receptor agonist LY 171555, but failed to change the effect of the activation of both D1 and D2 receptors.
    Abraini JH; Fechtali T; Rostain JC
    Neuroscience; 1992 Sep; 50(2):395-402. PubMed ID: 1359460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Local cerebral glucose utilization after D1 receptor stimulation in 6-OHDA lesioned rats: effect of sensitization (priming) with a dopaminergic agonist.
    Morelli M; Pontieri FE; Linfante I; Orzi F; Di Chiara G
    Synapse; 1993 Mar; 13(3):264-9. PubMed ID: 8098880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease.
    Calabresi P; Mercuri NB; Sancesario G; Bernardi G
    Brain; 1993 Apr; 116 ( Pt 2)():433-52. PubMed ID: 8096420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of dopaminergic terminal excitability by D1 selective agents: further characterization.
    Diana M; Young SJ; Groves PM
    Neuroscience; 1991; 42(2):441-9. PubMed ID: 1680226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Further studies on the interaction between bromocriptine and SKF38393 in reserpine and alpha methyl-para-tyrosine-treated mice.
    Jackson DM; Ross SB; Hashizume M
    Psychopharmacology (Berl); 1988; 94(3):321-7. PubMed ID: 2895938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral and neurochemical effects of chronic administration of reserpine and SKF-38393 in rats.
    Neisewander JL; Lucki I; McGonigle P
    J Pharmacol Exp Ther; 1991 May; 257(2):850-60. PubMed ID: 2033524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.